Drug interactions for the following drug(s)
Applies to: gabapentin 400 MG Oral Capsule <> Lunesta 3 MG Oral Tablet
The risk or severity of CNS depression can be increased when Gabapentin is combined with Eszopiclone.
Applies to: gabapentin 400 MG Oral Capsule <> gabapentin 400 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: gabapentin 400 MG Oral Capsule <> Lunesta 3 MG Oral Tablet
Drug1 (rxcui = 310432, name = gabapentin 400 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 540411, name = eszopiclone 3 MG Oral Tablet [Lunesta], tty = SBD). Drug1 is resolved to gabapentin, Drug2 is resolved to eszopiclone and interaction asserted in DrugBank between Gabapentin and Eszopiclone. Drug1 is resolved to eszopiclone, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Eszopiclone and Gabapentin enacarbil.
Applies to: gabapentin 400 MG Oral Capsule <> gabapentin 400 MG Oral Capsule
Drug1 (rxcui = 310432, name = gabapentin 400 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310432, name = gabapentin 400 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.